New biomarker could track progression of Alzheimer’s disease

FHS
July 14, 2023
12:02 am

Two pathologies drive the progression of Alzheimer’s disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.

Licensing agreements for innovator GLP1R drugs weigh in with over $6.2bn in 2024 – Pharmaceutical Technology

Innovator drugs targeting glucagon-like peptide-1 receptor (GLP1R) witnessed a 595% increase in total licensing agreement deal value from 2019 to 2024 year-to-date (YTD), with more

August 21, 2024

1 in 4 parents say their young child can’t go to sleep because of being worried or anxious, report reveals

The findings indicate that while the majority of parents have bedtime routines in place for their children, many children experience anxiety or disturbances at bedtime

June 19, 2024

Atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit | Psychedelic Invest

atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Jefferies Inaugural Biotech

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.